Hyperliquid Strategies expands equity financing vehicle to US$2.5 billion
Hyperliquid Strategies, a Nasdaq-listed money management company that focuses on Hyperliquid's native tokens, has significantly expanded its capital raising capabilities. The company increased its committed equity financing instrument with Chardan Capital Markets from $1 billion to $2.5 billion, a move disclosed in a Form 8-K filed with the Securities and Exchange Commission on September 1.
How the financing vehicle works
The agreement, originally signed in October 2025, allows Hyperliquid Strategies to regularly direct New York-based investment bank and broker-dealer Chardan to purchase newly issued common shares. Chardan could then resell the shares on the open market. The company controls the timing and size of each sale, and financing decisions are based on market conditions, stock trading prices and management's assessment of how funds are used.
It should be particularly pointed out that US$2.5 billion is the maximum amount of this financing instrument and is not the funds that have been received. The final amount raised may fall below this cap, and Chardan is not obligated to purchase the entire amount. Unlike traditional loans, selling shares under this arrangement will not generate interest expenses or repayment obligations, but will dilute the equity of existing shareholders because the shareholding represented by each share will be reduced.
There is also a Nasdaq-related cap: once cumulative sales under the original US$1 billion limit are exhausted, sales at a price less than US$12.02 per share must not exceed 19.99% of the shares in issue when the change takes effect unless approved by shareholders.
HYPE's Funding Strategy and Market Background
This expansion comes as the company approaches the upper limit of its original financing instruments. Hyperliquid Strategies has raised approximately $647 million through stock sales and held approximately 29.4 million $HYPE tokens in its pool as of the end of August. Funds from this financing instrument will be used for general corporate purposes and may include further purchases of $HYPE, but there is no fixed token allocation ratio or purchase deadline.
Market attention to Hyperliquid has increased in recent weeks. $HYPE rose more than 20% in August after U.S. President Donald Trump said Commodity Futures Trading Commission Chairman Michael Selig was working to bring the decentralized trading platform into the U.S. regulatory framework. Hyperliquid Strategies shares rose 30.4% over the same period. Despite having the same name as the agreement and holding its native tokens, the company stated that it remains independent and has no connection with the Hyperliquid agreement.

Exchange Ranking
Top Exchanges
24h Volume Ranking
Popularity Ranking
Exchange BTC Balance
Proof of Reserves
Decentralized Exchanges
Funding Rate
Funding Heatmap
Liquidation Data
Max Pain
Long/Short Ratio
Whale L/S Ratio
Binance/Okex/Huobi L/S
Bitfinex Margin L/S
ETF Tracker
Solana ETF
XRP ETF
Hong Kong ETF
Bitcoin Treasuries
Crypto Reversal
Ethereum Reserves
HyperLiquid Wallet Analysis
Hyperliquid Whale Watch
Large Transactions
On-chain Movement
Bitcoin ROI
Stablecoin Market Cap
Options Analysis
News
Articles
Economic Calendar
Features
Wallet
Contract Calculator
Security
Collections
Watchlist
Following
HYPE